Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-07

Clinical Trial Update: Criterion-learning Naming Treatment For Addressing Comprehension Deficits in Aphasia [NA]

View source ↗

Summary

An ongoing clinical trial evaluating a criterion-learning naming treatment for aphasia to address comprehension deficits. Enrollment is by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Albert Einstein Healthcare Network | Conditions: Aphasia | NA | Status: ENROLLING_BY_INVITATION